These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 31332076

  • 1. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
    Monti D, Mazzantini D, Tampucci S, Vecchione A, Celandroni F, Burgalassi S, Ghelardi E.
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
    [Abstract] [Full Text] [Related]

  • 2. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K, Sugimoto N, Hosaka S, Katafuchi-Nagashima M, Arakawa Y, Tatsumi Y, Jo Siu W, Pillai R.
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
    [Abstract] [Full Text] [Related]

  • 3. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M, Sugimoto N, Kawabata H, Yamakawa E, Kodera N, Pillai R, Tatsumi Y.
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
    Monti D, Saccomani L, Chetoni P, Burgalassi S, Tampucci S, Mailland F.
    Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
    [Abstract] [Full Text] [Related]

  • 6. Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer.
    Togni G, Mailland F.
    J Drugs Dermatol; 2010 May; 9(5):525-30. PubMed ID: 20480796
    [Abstract] [Full Text] [Related]

  • 7. In vitro antimycotic activity and nail permeation models of a piroctone olamine (octopirox) containing transungual water soluble technology.
    Dubini F, Bellotti MG, Frangi A, Monti D, Saccomani L.
    Arzneimittelforschung; 2005 May; 55(8):478-83. PubMed ID: 16149717
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
    Täuber A, Müller-Goymann CC.
    Mol Pharm; 2014 Jul 07; 11(7):1991-6. PubMed ID: 24490976
    [Abstract] [Full Text] [Related]

  • 9. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Jo Siu WJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, Fothergill A.
    Antimicrob Agents Chemother; 2013 Apr 07; 57(4):1610-6. PubMed ID: 23318803
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of drug susceptibility test for Efinaconazole compared with conventional antifungal agents.
    Hur MS, Park M, Jung WH, Lee YW.
    Mycoses; 2019 Mar 07; 62(3):291-297. PubMed ID: 30427072
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
    Tabata Y, Takei-Masuda N, Kubota N, Takahata S, Ohyama M, Kaneda K, Iida M, Maebashi K.
    Antimicrob Agents Chemother; 2016 Feb 07; 60(2):1035-9. PubMed ID: 26643333
    [Abstract] [Full Text] [Related]

  • 12. Development of ciclopirox nail lacquer with enhanced permeation and retention.
    Thapa RK, Choi JY, Go TG, Kang MH, Han SD, Jun JH, Son MW, Yong CS, Kim JO.
    Arch Pharm Res; 2016 Jul 07; 39(7):953-9. PubMed ID: 27306785
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.
    Iwata A, Watanabe Y, Kumagai N, Katafuchi-Nagashima M, Sugiura K, Pillai R, Tatsumi Y.
    Antimicrob Agents Chemother; 2014 Aug 07; 58(8):4920-2. PubMed ID: 24867968
    [Abstract] [Full Text] [Related]

  • 14. In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis.
    Kubota-Ishida N, Takei-Masuda N, Kaneda K, Nagira Y, Chikada T, Nomoto M, Tabata Y, Takahata S, Maebashi K, Hui X, Maibach HI.
    Antimicrob Agents Chemother; 2018 Jan 07; 62(1):. PubMed ID: 29084749
    [Abstract] [Full Text] [Related]

  • 15. Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro.
    Lusiana, Reichl S, Müller-Goymann CC.
    Eur J Pharm Biopharm; 2013 Aug 07; 84(3):599-605. PubMed ID: 23419812
    [Abstract] [Full Text] [Related]

  • 16. Preparation and in vivo evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis.
    Lee BC, Pangeni R, Na J, Koo KT, Park JW.
    Drug Deliv; 2019 Dec 07; 26(1):1167-1177. PubMed ID: 31738083
    [Abstract] [Full Text] [Related]

  • 17. [Affinity of Luliconazole to Keratin Prepared from Healthy Human Nailand Porcine Hoof].
    Hasuko M, Toga T, Tsunemitsu T, Matsumoto T, Koga H, Hirano H, Tsuboi R.
    Med Mycol J; 2016 Dec 07; 57(1):J7-12. PubMed ID: 26936352
    [Abstract] [Full Text] [Related]

  • 18. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
    Kawai M.
    Med Mycol J; 2019 Dec 07; 60(3):71-74. PubMed ID: 31474693
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
    Shimamura T, Miyamae A, Imai A, Hirayanagi K, Iwanaga T, Kubota N, Shibuya K.
    Med Mycol J; 2016 Dec 07; 57(4):J141-J147. PubMed ID: 27904059
    [Abstract] [Full Text] [Related]

  • 20. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D, Saccomani L, Chetoni P, Burgalassi S, Senesi S, Ghelardi E, Mailland F.
    Br J Dermatol; 2010 Feb 01; 162(2):311-7. PubMed ID: 19886884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.